AIC
SYNH

Ameritas Investment Company’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Ameritas Investment Company’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-270
Closed -$20.5K – 2190
2021
Q1 		$20.5K Buy
+270
New +$20.4K ﹤0.01% 1288
2019
Q1 		– Sell
-163
Closed -$6K – 1873
2018
Q4 		$6K Buy
+163
New +$7.57K ﹤0.01% 1185

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Ameritas Investment Company's SYNH Position: Q2 2021 in Review

Ameritas Investment Company sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 270 shares — an estimated $20.5K sold.

Ameritas Investment Company first reported a position in SYNH in Q4 2018 and held it in 2 quarters. The position peaked at $20.5K in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Ameritas Investment Company reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 270 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $20.5K.
  • Ameritas Investment Company first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Syneos Health, Inc. Class A Common Stock position peaked at $20.5K in Q1 2021.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.